Payal K Gurnani

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Topics

Prognostic Factors

Acute Respiratory Distress Syndrome

Extracorporeal Membrane Oxygenation

Intensive Care Unit

Top Venues

ASAIO journal (American Society for Artificial Internal Organs : 1992)

The Annals of pharmacotherapy

Pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Payal K Gurnani, Lauren A Michalak, Deborah Tabachnick, Michael Kotwas, Antone J Tatooles
Outcomes of Extubated COVID and Non-COVID Patients Receiving Awake Venovenous Extracorporeal Membrane Oxygenation. ASAIO journal (American Society for Artificial Internal Organs : 1992) 68 (4) (2022)
Payal K Gurnani, Gary D Peksa, Nicholas G Panos, Joshua M DeMott
Under the Microscope: A Look Into the Role of Critical Care Pharmacists During the COVID-19 Pandemic. Journal of pharmacy practice (2021)
Attiya A Khan, Payal K Gurnani, Gary Daniel Peksa, William L Whittier, Joshua M DeMott
Bisphosphonate Versus Bisphosphonate and Calcitonin for the Treatment of Moderate to Severe Hypercalcemia of Malignancy. The Annals of pharmacotherapy 55 (3) (2020)
Jaclyn Sullivan, Erica Bak, Mary Jane Sullivan, Payal K Gurnani
Predictive value of scoring tools in determining heparin-induced thrombocytopenia in patients on extracorporeal membrane oxygenation. Perfusion 35 (5) (2019)
Drayton A Hammond, Payal K Gurnani, Alexander H Flannery, Keaton S Smetana, Jennifer C Westrick, Ishaq Lat, Megan A Rech
Scoping Review of Interventions Associated with Cost Avoidance Able to Be Performed in the Intensive Care Unit and Emergency Department. Pharmacotherapy 39 (3) (2019)
Payal K Gurnani, Allison Bohlmann, Robert J March
Prolonged use of eptifibatide as a bridge to maintain drug-eluting stent patency in a patient receiving extracorporeal membrane oxygenation. Perfusion 33 (8) (2018)